160 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental Laws”), (ii) have received all permits and other
424B3
ORKA
Oruka Therapeutics Inc.
1 Aug 24
Prospectus supplement
4:10pm
of care;
Reduction in the need for catheter ablation, electrical cardioversion, or toxic anti-arrhythmic drugs;
Maintenance of rhythm control after
425
ORKA
Oruka Therapeutics Inc.
3 Apr 24
Business combination disclosure
7:33am
toxic, infectious, carcinogenic, reactive, corrosive, ignitable or flammable chemical, or chemical compound, or hazardous substance, material or waste
8-K
EX-2.1
7iwmzj0kfpp0vsm
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am
424B5
f11x7
18 Mar 22
Prospectus supplement for primary offering
4:15pm
424B5
2nr0ryx4c a29bsp
6 Apr 21
Prospectus supplement for primary offering
4:36pm